These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Development of oral therapies for multiple sclerosis--fingolimod, cladribine and other drugs].
    Author: Hecht B.
    Journal: Med Monatsschr Pharm; 2010 Apr; 33(4):120-30; quiz 131-2. PubMed ID: 20429402.
    Abstract:
    Orally disposable drugs for the treatment of multiple sclerosis have been research topics for long-term. Actually there are several drugs in clinical trial. Their mode of action differs among themselves and from established therapeutic agents. While cladribine acts as an antimetabolite and reduces lymphocytopoiesis, fingolimod influences circulation of lymphocytes. Fampridine alleviates symptoms by blocking potassium-channels. These and other drugs which are currently examined for oral administration are presented. The main focus is on the mode of action of these new drugs, in addition important results of clinical trials are summarized.
    [Abstract] [Full Text] [Related] [New Search]